Biphasic Resorbable Calcium Phosphate Ceramic for Bone Implants and Local Alendronate Delivery

A novel biphasic calcium phosphate ceramic composed of tricalcium phosphate (TCP) and calcium pyrophosphate (CP) is synthesized in order to tailor the biodegradation behavior of the ceramic. The results show that biphasic TCP/CP ceramic has a strength of 62.2 ± 2.1 MPa, which is superior to single‐phase TCP and CP ceramics, which show strengths of 44.3 ± 3.0 and 53.0 ± 4.8 MPa, respectively. In addition, biphasic TCP/CP ceramic displays a controlled strength degradation from 62.2 ± 2.1 to 40.5 ± 1.0 MPa in stimulated body fluid over a period of 28 d. An in vitro cell materials interaction study using human fetal osteoblast cells indicates that TCP/CP ceramic is cytocompatible. TCP/CP ceramic also show a good loading capacity for alendronate. Adsorption of alendronate (AD) on the TCP/CP surface is found to proceed via ligand exchange mechanism and the in vitro release profile of AD from TCP/CP surface is characterized by an initial fast release followed by a slow and sustained release. Strong electrostatic interactions between AD groups and surface Ca2+ ions enable the slow and sustained release of AD. These results demonstrate that the newly developed biphasic ceramic, with its controlled strength degradation and drug release, shows promise for use in orthopedic and tissue engineering applications. A novel biphasic calcium phosphate ceramic composed of tricalcium phosphate and calcium pyrophosphate is synthesized to tailor the mechanical (see image) and bioresorable properties. The biphasic ceramic have excellent biodegradation properties, revealing the potential of this system to be used as a resorbable bone graft material.